BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33412261)

  • 1. Risk of Hypothyroidism in Women After Radiation Therapy for Breast Cancer.
    Choi SH; Chang JS; Byun HK; Son NH; Hong CS; Hong N; Park Ms YI; Kim J; Kim JS; Kim YB
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):462-472. PubMed ID: 33412261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.
    Bazan JG; Healy E; Beyer S; Kuhn K; DiCostanzo D; Smith TL; Jhawar S; White JR
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1159-1171. PubMed ID: 32711036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
    Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and time of occurrence of regional recurrence in stage I-II breast cancer: value of adjuvant irradiation.
    Fodor J; Toth J; Major T; Polgar C; Nemeth G
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):281-7. PubMed ID: 10760420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy.
    Schlafstein A; Liu Y; Goyal S; Kahn S; Godette K; Lin J; Torres MA; Royce TJ; Patel SA
    Clin Breast Cancer; 2022 Feb; 22(2):127-135. PubMed ID: 34229943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial.
    Jagsi R; Barlow WE; Woodward WA; Connolly E; Mahtani R; Shumway D; Speers C; Stecklein SR; Zeidan Y; Zhang H; Sharma P; Pusztai L; Hortobagyi GN; Kalinsky K
    JAMA Oncol; 2023 Aug; 9(8):1083-1089. PubMed ID: 37410451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study.
    Tunio MA; Al Asiri M; Bayoumi Y; Stanciu LG; Al Johani N; Al Saeed EF
    J Cancer Res Ther; 2015; 11(4):684-9. PubMed ID: 26881502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.
    Stecklein SR; Park M; Liu DD; Valle Goffin JJ; Caudle AS; Mittendorf EA; Barcenas CH; Mougalian S; Woodward WA; Valero V; Sahin AA; Yang WT; Shaitelman SF
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):568-577. PubMed ID: 29928946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.
    Ho AY; Ballangrud A; Li G; Gupta GP; McCormick B; Gewanter R; Gelblum D; Zinovoy M; Mueller B; Mychalczak B; Dutta P; Borofsky K; Parhar P; Reyngold M; Braunstein LZ; Chawla M; Krause K; Freeman N; Siu CT; Cost Z; Arnold BB; Zhang Z; Powell SN
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1100-1108. PubMed ID: 30508620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
    Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
    Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Thyroid Radiation Dose and Hypothyroidism in Breast Cancer Patients Undergoing Volumetric Modulated Arc Therapy for Regional Nodal Irradiation.
    Koh HK; Park Y; Koo T; Cheong KH; Lee MY; Park HJ; Kim KJ; Park S; Han T; Kang SK; Ha B; Yoon JW; Kim MY; Bae H
    In Vivo; 2023; 37(5):2340-2346. PubMed ID: 37652492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
    Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
    Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported acute fatigue in elderly breast cancer patients treated with and without regional nodal radiation.
    Misra S; Lee G; Korzets Y; Wang L; Lau A; Koch CA; Croke J; Helou J
    Breast Cancer Res Treat; 2020 Sep; 183(2):391-401. PubMed ID: 32651754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
    Gingras I; Holmes E; De Azambuja E; Nguyen DH; Izquierdo M; Anne Zujewski J; Inbar M; Naume B; Tomasello G; Gralow JR; Wolff AC; Harris L; Gnant M; Moreno-Aspitia A; Piccart MJ; Azim HA
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we consider thyroid gland as an organ at risk in carcinoma breast patients receiving adjuvant radiation by conformal technique? A single institute dosimetric study.
    Madisetty A; Suryadevara A; Chinta SK; Vuppu S; R Marella VR
    Indian J Cancer; 2020; 57(4):393-397. PubMed ID: 33078745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hypothyroidism in older breast cancer patients treated with radiation.
    Smith GL; Smith BD; Giordano SH; Shih YC; Woodward WA; Strom EA; Perkins GH; Tereffe W; Yu TK; Buchholz TA
    Cancer; 2008 Mar; 112(6):1371-9. PubMed ID: 18213620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?
    Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G
    Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.